ACTCA, Inc.

Los Angeles, California 90017

0 studies enrolling now · 3 studies all time

What they study most

Diabetes Type 2, Functional Constipation in Children Ages 6-17 Years, Irritable Bowel Syndrome With Constipation

Studies at this site

• A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation — Stopped early
• Phase II Safety and Efficacy Study of Oral ORMD-0801 in Patients With Type 2 Diabetes Mellitus — Completed
• A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 6-17 Years Who Fulfill Modified Rome III Criteria for Child/Adolescent Functional Constipation (FC) — Completed